04.06 13:03 | dpa-AFX: *IDEXX LABORATORIES ANNOUNCES LAUNCH OF THE CATALYST PANCREATIC LIPASE TEST |
01.05 13:33 | dpa-AFX: IDEXX Laboratories Q1 24 Earnings Conference Call At 8:30 AM ET |
01.05 13:12 | dpa-AFX: ROUNDUP: IDEXX Laboratories Q1 Profit Up, Beats Estimates; Trims Annual Outlook |
01.05 12:40 | dpa-AFX: IDEXX Laboratories Inc Announces Advance In Q1 Bottom Line, Beats estimates |
01.05 12:39 | dpa-AFX: *IDEXX LABS NOW EXPECTS FY24 REVENUE OF $3.895 BLN - $3.965 BLN, EPS OF $10.82 - $11.20 |
01.05 12:37 | dpa-AFX: *IDEXX LABS Q1 GROSS PROFIT $593.07 MLN VS. $542.97 MLN LAST YEAR |
01.05 12:37 | dpa-AFX: *IDEXX LABS Q1 REVENUE $964.10 MLN VS. $900.19 MLN LAST YEAR |
01.05 12:36 | dpa-AFX: *IDEXX LABS Q1 OPERATING INCOME $298.96 MLN VS. $280.40 MLN LAST YEAR |
01.05 12:35 | dpa-AFX: *IDEXX LABS Q1 NET INCOME $235.58 MLN VS. $214.05 MLN LAST YEAR |
01.05 12:35 | dpa-AFX: *IDEXX LABS Q1 COMPARABLE EPS $2.71 VS. $2.49 LAST YEAR |
01.05 12:35 | dpa-AFX: *IDEXX LABS Q1 EPS $2.81 VS. $2.55 LAST YEAR |
15.02 13:07 | dpa-AFX: *IDEXX LABORATORIES ANNOUNCES LAUNCH OF VELLO, A SOFTWARE SOLUTION |
05.02 16:19 | dpa-AFX: IDEXX Laboratories Shares Rise On Upbeat Q4 Results |
05.02 13:33 | dpa-AFX: IDEXX Laboratories Q4 23 Earnings Conference Call At 8:30 AM ET |
05.02 13:18 | dpa-AFX: IDEXX Laboratories Expects Annual Earnings, Revenue To Climb |
05.02 12:43 | dpa-AFX: IDEXX Laboratories Inc Announces Rise In Q4 Income, Beats estimates |
05.02 12:40 | dpa-AFX: *IDEXX LABORATORIES EXPECTS FY24 EPS OF $10.84 - $11.33 |
05.02 12:40 | dpa-AFX: *IDEXX LABORATORIES EXPECTS FY24 REVENUE OF $3.930 BLN - $4.040 BLN |
05.02 12:39 | dpa-AFX: *IDEXX LABORATORIES Q4 NON-GAAP EPS $2.34 VS. $2.00 LAST YEAR |
05.02 12:36 | dpa-AFX: *IDEXX LABORATORIES Q4 REVENUE $901.60 MLN VS. $828.57 MLN LAST YEAR |
|